1. Oroxylin A induces G2/M phase cell-cycle arrest via inhibiting Cdk7-mediated expression of Cdc2/p34 in human gastric carcinoma BGC-823 cells.
- Author
-
Yang Y, Hu Y, Gu HY, Lu N, Liu W, Qi Q, Zhao L, Wang XT, You QD, and Guo QL
- Subjects
- Blotting, Western, CDC2 Protein Kinase metabolism, Cell Division drug effects, Cell Line, Tumor, Cyclin A drug effects, Cyclin A metabolism, Cyclin B drug effects, Cyclin B metabolism, Cyclin B1, Cyclin-Dependent Kinases drug effects, Cyclin-Dependent Kinases metabolism, Flow Cytometry, G2 Phase drug effects, Humans, Stomach Neoplasms drug therapy, Stomach Neoplasms pathology, Tetrazolium Salts, Thiazoles, Cyclin-Dependent Kinase-Activating Kinase, Antineoplastic Agents, Phytogenic pharmacology, CDC2 Protein Kinase drug effects, Flavonoids pharmacology, Gene Expression Regulation drug effects
- Abstract
We reported previously that oroxylin A, a natural product isolated from Scutellariae Radix, was a potent apoptosis inducer of human hepatoma HepG2 cells. In this study, cell-cycle arrest of BGC-823 human gastric carcinoma cells caused by oroxylin A has been investigated. Based on our 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay and flow cytometric analysis, treatment of BGC-823 cells with growth suppressive concentrations of oroxylin A caused an irreversible arrest in the G2/M phase of the cell cycle. Western blot analysis demonstrated that oroxylin A-induced cell-cycle arrest in BGC-823 cells was associated with a significant decrease in cdc2/p34, cyclin B1 and cyclin A expression. In addition, oroxylin A-treated cells decreased the expression of Cdk7, which was responsible for the low expression of M phase promoting factor (cyclin B1/Cdc2). The results suggested that oroxylin A induced G2/M phase cell-cycle arrest via inhibiting Cdk7-mediated expression of Cdc2/p34 in human gastric carcinoma BGC-823 cells.
- Published
- 2008
- Full Text
- View/download PDF